News/ News/ Oncology Numab raises $110m to develop cancer bispecific antibodies Richard Staines cancer, Novo Holdings, Numab 0 Comment Switzerland’s Numab has raised 100 million Swiss francs – around $110 million – in Series C financing to Share X Numab raises $110m to develop cancer bispecific antibodies https://pharmaphorum.com/news/numab-raises-110m-to-develop-cancer-bispecific-antibodies/
